Oxlumo 94.5 mg / 0.5 ml

Oxlumo 94.5 mg / 0.5 ml is a medicine authorised by Swissmedic under authorisation number 68239. The authorisation holder is Alnylam Switzerland GmbH. The medicinal product code is Transplant: gene therapy product and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 01 December 2021 and the authorisation is valid without a time limit. ATC code A16AX18 places the medicine in the group Other alimentary tract and metabolism products.

  • Dispensing category B
  • Authorisation number 68239
  • ATC A16AX18
  • Transplant: gene therapy product
Authorisation data
Authorisation number68239
NameOxlumo 94.5 mg / 0.5 ml
Full nameOxlumo 94.5 mg / 0.5 ml, Injektionslösung
Authorisation holderAlnylam Switzerland GmbH
Medicinal product codeTransplant: gene therapy product
Dispensing categoryB · Prescription only
ATC codeA16AX18
First authorisation01 December 2021
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Oxlumo 94.5 mg / 0.5 ml, InjektionslösungB01 December 2021

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)A16AX1804.99.0.B

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Oxlumo 94.5 mg / 0.5 ml authorised in Switzerland?

Yes. Oxlumo 94.5 mg / 0.5 ml is authorised by Swissmedic under authorisation number 68239, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Oxlumo 94.5 mg / 0.5 ml have?

Oxlumo 94.5 mg / 0.5 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Oxlumo 94.5 mg / 0.5 ml?

The authorisation holder is Alnylam Switzerland GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com